Visit COVID-19 resources

[Skip to Content]

Early treatment of acute submacular haemorrhage secondary to wet AMD using intravitreal tissue plasminogen activator, C3F8, and an anti-VEGF agent – (Eye 30, 952 (July 2016))

7 July 2016

This news item is available to RCOphth members only, please log in below to access.

Members Login